Diagnosis of canine hyperadrenocorticism

Veterinary Clinics of North America - Small Animal Practice

Volumn 31, Issue 5, 2001, Pages 985-1003

  Behrend, E N ^a   Kemppainen, R J ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CORTICOTROPIN; CREATININE; HYDROCORTISONE; TETRACOSACTIDE;

CORTICOTROPIN TEST; CREATININE URINE LEVEL; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DOG; EARLY DIAGNOSIS; HYDROCORTISONE URINE LEVEL; HYPERADRENOCORTICISM; HYPOPHYSIS DISEASE; NONHUMAN; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; SCREENING TEST;

EID: 0034843391     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-5616(01)50009-1     Document Type: Review

References (95)

1. Sequential morphologic and clinicopathologic alterations in dogs with experimentally induced glucocorticoid hepatopathy
2. Use of x-ray-computed tomography as an aid in localization of adrenal masses in the dog
3. Ultrasonic evaluation of the adrenal glands in dogs
4. Glucocorticoid therapy: Pharmacology, indications and complications
5. Frequency of pulmonary mineralization and hypoxemia in 21 dogs with pituitary-dependent hyperadrenocorticism
6. Magnetic resonance imaging of the brain in dogs with recently diagnosed but untreated pituitary-dependent hyperadrenocorticism
7. One-year follow-up evaluation of magnetic resonance imaging of the brain in dogs with pituitary-dependent hyperadrenocorticism
8. Retrospective ultrasonographic evaluation of adrenal lesions in 26 dogs
9. Multiple endocrine abnormalities in basenji dogs with renal tubular dysfunction
10. Evaluation of the hypothalamic-pituitary-adrenal axis in clinically stressed dogs
11. Effects of phenobarbital administration on results of serum biochemical analyses and adrenocortical function tests in epileptic dogs
12. Effect of non-adrenal illness, anesthesia and surgery on plasma cortisol concentrations in dogs
13. Diagnostic approach to canine Cushing's syndrome by veterinary specialists
14. Prednisolone-induced hematologic, biochemical and histological changes in the dog
15. Corticosterotd induction of an isoenzyme of alkaline phosphatase in the dog
16. Ultrasonographic adrenal gland measurements in dogs without evidence of adrenal disease
17. Magnetic resonance imaging for diagnosis of pituitary macrotumors in dogs
18. Effects of short- and long-term administration of phenobarbital on endogenous ACTH concentration and the results of ACTH stimulation tests in dogs
19. Isoenzymes of canine plasma alkaline phosphatase: An investigation using isoelectric focusing and related to diagnosis
20. The measurement of canine steroid-induced alkaline phosphatase by L-phenylalanine inhibition
21. Combined dexamethasone suppression and cosyntropin (synthetic ACTH) stimulation test in the dog: New approach to testing of adrenal gland function
22. Stages of hyperadrenocorticism: Response of hyperadrenocorticoid dogs to the combined dexamethasone suppression/ACTH stimulation test
23. Evaluation of canine hyperadrenocorticism using computed tomography
24. Comparison of ACTH response and dexamethasone suppression as screening tests in canine hyperadrenocorticism
25. Distinguishing dogs with functioning adrenocortical tumors from dogs with pituitary-dependent hyperadrenocorticism
26. Effect of functional adrenocortical tumors on plasma cortisol and corticotropin concentrations in dogs
27. Evaluation of a combined dexamethasone suppression/ACTH stimulation test in dogs with hyperadrenocorticism
28. Evaluation of a six-hour combined dexamethasone suppression/ACTH stimulation test in dogs with hyperadrenocorticism
29. Diagnostic value of steroid-induced isoenzyme of alkaline phosphatase in the dog
30. Hyperadrenocorticism (Cushing's syndrome)
31. Urine cortisol: Creatinine ratio as a screening test for hyperadrenocorticism in dogs
32. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs
33. The synthetic ACTH stimulation test and measurement of endogenous plasma ACTH levels: Useful diagnostic indicators for adrenal disease in dogs
34. Use of low- and high-dose dexamethasone tests for distinguishing pituitary-dependent from adrenal tumor hyperadrenocorticism in dogs
35. Hyperadrenocorticism caused by bilateral adrenocortical neoplasia in dogs: Four cases (1983-1988)
36. Comparison of serum cortisol concentrations in dinically normal dogs after administration of freshly reconstituted versus reconstituted and stored frozen cosyntropin
37. Concurrent pituitary and adrenal tumors in dogs with hyperadrenocorticism: 17 cases (1978-1995)
38. Ultrasonographic parameters of normal canine adrenal glands: Comparison to necropsy findings
39. Evaluation of routine abdominal ultrasonography as a technique for imaging the canine adrenal glands
40. Ultrasonographic characteristics of the adrenal glands in dogs with pituitary-dependent hyperadrenocorticism: Comparison with normal dogs
41. Ultrasonographic characteristics of both adrenal glands in 15 dogs with functional adrenocortical tumors
42. Diagnostic value of canine serum alkaline phosphatase and alkaline phosphatase isoenzymes
43. The radiological features of canine Cushing's syndrome: A review of forty-eight cases
44. Evaluation of the urinary cortisol: Creatinine ratio in the diagnosis of hyperadrenocorticism in dogs
45. Changes in adrenal cortisol secretion as reflected in the urinary cortisol/creatinine ratio in dogs
46. Adrenal ultrasonography in the dog
47. Effects of disease on the results of diagnostic tests for use in detecting hyperadrenocorticism in dogs
48. CVT update: Sample collection and testing protocols in endocrinology
49. Effects of single intravenous doses of dexamethasone on baseline plasma cortisol concentrations and response to synthetic ACTH in healthy dogs
50. Evidence for episodic but not circadian activity in plasma concentrations of adrenocorticotrophin, cortisol and thyroxine in dogs
51. Evaluation of a low-dose synthetic adrenocorticotropic hormone stimulation test in clinically normal dogs and dogs with naturally developing hyperadrenocorticism
52. Diagnostic value of alkaline phosphatase isoenzyme separation by affinity electrophoresis in the dog
53. Mitotane (o,p′-DDD) treatment of 200 dogs with pituitary-dependent hyperadrenocorticism
54. Mitotane treatment of 32 dogs with cortisol-secreting adrenocortical neoplasms
55. Pituitary tumor size, neurologic signs, and relation to endocrine test results in dogs with pituitary-dependent hyperadrenocorticism: 43 cases (1980-1990)
56. Correlation between impairment of glucocorticoid feedback and the size of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism
57. A rapid radioimmunoassay method for the evaluation of plasma cortisol levels and adrenal function in the dog
58. Canine hyperadrenocorticism: Pretreatment clinical and laboratory evaluation of 117 cases
59. Ultrasonographic diagnosis of an adrenocortical carcinoma in a dog
60. The computed tomographic enhancement pattern of the normal canine pituitary gland
61. Comparison of two low-dose dexamethasone suppression protocols as screening and discrimination tests in dogs with hyperadrenocorticism
62. Transsphenoidal hypophysectomy for the treatment of pituitary-dependent hyperadrenocorticism in dogs
63. Effects of long-term phenobarbital treatment on the thyroid and adrenal axis and adrenal function tests in dogs
64. Pituitary macroadenomas and macroadenocarcinomas in dogs treated with mitotane for pituitary-dependent hyperadrenocorticism: 13 cases (1981-1986)
65. Dynamic adrenal function testing in eight dogs with hyperadrenocorticism associated with adrenocortical neoplasia
66. Simple quantitative assay for canine steroid-induced alkaline phosphatase
67. Radiographic features of canine hyperadrenocorticism caused by autonomously functioning adrenocortical tumors: 23 cases (1978-1976)
68. Pathophysiology of canine pituitary-dependent hyperadrenocorticism (canine Cushing's disease)
69. Plasma cortisol response to exogenous ACTH in 22 dogs with hyperadrenocorticism caused by adrenocortical neoplasia
70. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Addison's disease and Cushing's syndrome: Basal concentrations
71. Gray-scale ultrasonography in the diagnosis of adrenal neoplasia in dogs: Six cases (1981-1986)
72. Canine hyperadrenocorticism due to adrenocortlcal neoplasia
73. Assessment of two tests for the diagnosis of canine hyperadrenocorticism
74. Source of serum alkaline phosphatase in clinically normal and diseased dogs: A clinical study
75. Diagnostic evaluation of canine serum alkaline phosphatase by immunochemical means and interpretation of results
76. Neurologic, endocrinologic, and pathologic findings associated with large pituitary tumors in dogs: Eight cases (1976-1984)
77. Expanding applications of abdominal ultrasonography
78. Osteopenia and other radiographic signs in canine hyperadrenocorticism
79. Evaluation of a urine cortisol: Creatinine ratio as a screening test for hyperadrenocorticism in dogs
80. Assessment of corticosteroid-induced isoenzyme as a screening test for hyperadrenocorticism in dogs
81. Urinary corticoids in the diagnosis of canine hyperadrenocorticism
82. Corticosteroid-induced alkaline phosphatase isoenzyme in the diagnosis of canine hypercorticism
83. Multiple endocrine neoplasias in a dog: Corticotrophic tumour, bilateral adrenocortical tumours and pheochromocytoma
84. Computed tomographic characteristics of primary brain tumors in 50 dogs
85. Dynamic CT of the pituitary gland in dogs
86. Comparison of results of adrenocorticotropic hormone stimulation and low-dose dexamethasone suppression test with necropsy findings in dogs: 81 cases (1985-1995)
87. Influence of veterinary care on the urinary corticoid: Creatinine ratio in dogs
88. X-ray-computed tomography, nephrotomography, and ultrasonography of the adrenal glands of healthy dogs
89. Assessment of survey radiography and comparison with x-ray computed tomography for detection of hyperfunctioning adrenocortical tumors in dogs
90. Computed tomography in the diagnosis of canine hyperadrenocorticism not suppressible by dexamethasone
91. Nephrotomography and ultrasonography for the localization of hyperfunctioning adrenocortical tumors in dogs
92. Plasma cortisol responses to three corticotrophic preparations in normal dogs
93. Imaging techniques for facilitating diagnosis of hyperadrenocorticism in dogs and cats
94. Screening tests to diagnose hyperadrenocorticism in cats and dogs